Open access

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
Marie Kroemer, Celia Turco, Laurie Spehner, Julien Viot, Idir Idirène, Adeline Bouard, Elodie Renaude, Marina Deschamps, Yann Godet, Olivier Adotévi, Samuel Limat, Bruno Heyd, Marine Jary, Romain Loyon, Christophe Borg

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001478; DOI: 10.1136/jitc-2020-001478
Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000331corr1; DOI: 10.1136/jitc-2019-000331corr1
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4⁺, CD8⁺ T cells, and M1 macrophages
Martin Hart, Laura Nickl, Barbara Walch-Rueckheim, Lena Krammes, Stefanie Rheinheimer, Caroline Diener, Tanja Taenzer, Tim Kehl, Martina Sester, Hans-Peter Lenhof, Andreas Keller, Eckart Meese

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001617; DOI: 10.1136/jitc-2020-001617
Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy
Afaf Abed, Leslie Calapre, Johnny Lo, Suzana Correia, Samantha Bowyer, Abha Chopra, Mark Watson, Muhammad Adnan Khattak, Michael Millward, Elin Solomonovna Gray

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001620; DOI: 10.1136/jitc-2020-001620
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer
Paul Johannet, Amelia Sawyers, Yingzhi Qian, Samuel Kozloff, Nicholas Gulati, Douglas Donnelly, Judy Zhong, Iman Osman

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001674; DOI: 10.1136/jitc-2020-001674
Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy
Won Jin Ho, Gaurav Sharma, Qingfeng Zhu, Genevieve Stein-O'Brien, Jennifer Durham, Robert Anders, Aleksandra Popovic, Guanglan Mo, Ihab Kamel, Matthew Weiss, Elizabeth Jaffee, Elana J Fertig, Mark Yarchoan

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000932; DOI: 10.1136/jitc-2020-000932
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
Victoria Atkinson, Adnan Khattak, Andrew Haydon, Melissa Eastgate, Amitesh Roy, Prashanth Prithviraj, Christian Mueller, Chrystelle Brignone, Frederic Triebel

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001681; DOI: 10.1136/jitc-2020-001681
Efficacy and immune-related adverse event associations in avelumab-treated patients
Karen Kelly, Juliane Manitz, Manish R Patel, Sandra P D’Angelo, Andrea B Apolo, Arun Rajan, Vijay Kasturi, Isabell Speit, Marcis Bajars, John Warth, James L Gulley

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001427; DOI: 10.1136/jitc-2020-001427
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
Jennifer L Marté, Nicole J Toney, Lisa Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001019; DOI: 10.1136/jitc-2020-001019
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy
Yong Qin, Kathryn Bollin, Mariana Petaccia de Macedo, Fernando Carapeto, Kevin B Kim, Jason Roszik, Khalida M Wani, Alexandre Reuben, Sujan T Reddy, Michelle D Williams, Michael T Tetzlaff, Wei-Lien Wang, Dan S Gombos, Bita Esmaeli, Alexander J Lazar, Patrick Hwu, Sapna P Patel

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000960; DOI: 10.1136/jitc-2020-000960

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages